2017 Half Year Media Release
Filed with ASX · · 4 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Mayne Pharma launches Butalbital / APAP tablets in the US
- Mayne Pharma launches Amiodarone 100mg tablets
- Mayne Pharma launches Fabior and Sorilux in the US
- Update on Status of DOJ Investigation
- S&P DJ Indices Announces March Quarterly Rebalance
Later from Mayne Pharma
- License and supply agreement for generic Nuvaring in the US
- Mayne Pharma acquires rights to generic Duragesic in the US
- Clarification statement
- FDA approval and first generic launch of Acticlate tablets
- Mayne Pharma adds two products to its Australian portfolio
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma